Crybg1-KO Mouse

Crybg1, whose exact function is still being explored, has been associated with multiple biological contexts. It belongs to the βγ -crystal lens superfamily, and members of this family are often involved in various cellular processes, though the precise pathways Crybg1 participates in are not fully clear [4,5]. Given its associations with different diseases, genetic models could potentially be valuable in further elucidating its function.

In breast cancer cell line MFM-223, potential oncogenic fusion transcripts involving Crybg1, such as FGFR2::CRYBG1 and RTN4IP1::CRYBG1, were identified, suggesting its possible role in cancer-related gene regulation [1]. In a study on COVID-19, the rs1770731 variant in Crybg1 was identified as potentially linked to a protective effect against the clinical severity of COVID-19 in individuals from the Brazilian Amazon [2]. In rheumatoid arthritis, Crybg1 was identified as one of the 4 key hub genes associated with neutrophil extracellular traps, indicating its potential role in the pathogenesis of this autoimmune disease [3]. In an extranodal NK/T-cell lymphoma cell line, high expression of Crybg1 was observed, along with genes related to tumor suppression, suggesting its possible role in the regulation of this lymphoma [4].

In summary, Crybg1 seems to be implicated in multiple disease conditions, including cancer, COVID-19, and rheumatoid arthritis. Its associations with oncogenic fusion transcripts, disease-protective variants, and key cellular processes in diseases highlight its potential importance in understanding the molecular mechanisms of these diseases. However, more research, potentially through gene knockout or conditional knockout models, is needed to fully clarify its functions and roles in these biological contexts.

References:

1. Pommerenke, Claudia, Nagel, Stefan, Haake, Josephine, Steenpass, Laura, Eberth, Sonja. 2024. Molecular Characterization and Subtyping of Breast Cancer Cell Lines Provide Novel Insights into Cancer Relevant Genes. In Cells, 13, . doi:10.3390/cells13040301. https://pubmed.ncbi.nlm.nih.gov/38391914/

2. Barros, Maria Clara, de Souza, Jorge Estefano Santana, Gomes, Daniel Henrique F, de Souza, Sandro José, Ribeiro-Dos-Santos, Ândrea. 2024. Unraveling the protective genetic architecture of COVID-19 in the Brazilian Amazon. In Scientific reports, 14, 27332. doi:10.1038/s41598-024-78170-3. https://pubmed.ncbi.nlm.nih.gov/39521879/

3. Li, Yang, Liu, Jian, Sun, Yue, Cong, Chengzhi, Chen, Yiming. 2025. Deciphering hub genes and immune landscapes related to neutrophil extracellular traps in rheumatoid arthritis: insights from integrated bioinformatics analyses and experiments. In Frontiers in immunology, 15, 1521634. doi:10.3389/fimmu.2024.1521634. https://pubmed.ncbi.nlm.nih.gov/39845946/

4. Sato, Shoko, Ishii, Midori, Tachibana, Kota, Ando, Jun, Ando, Miki. 2023. Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis. In Experimental hematology, 130, 104132. doi:10.1016/j.exphem.2023.11.006. https://pubmed.ncbi.nlm.nih.gov/38029851/

5. Wu, Fang, Cheng, Liangkai, Yu, Qi, Li, Hong, Wang, Caiyan. 2018. Purification and Functional Characterization of the C-Terminal Domain of the β-Actin-Binding Protein AIM1 In Vitro. In Molecules (Basel, Switzerland), 23, . doi:10.3390/molecules23123281. https://pubmed.ncbi.nlm.nih.gov/30544954/